List of Tables
Table 1 United States Solid Tumor Testing Market Size, By Testing Type, By Value, 2019-2029
Table 2 United States Solid Tumor Testing Market Size, By Cancer Type, By Value, 2019-2029
Table 3 United States Solid Tumor Testing Market Size, By End User, By Value, 2019-2029
Table 4 Agilent Technologies Company Overview
Table 5 Agilent Technologies Financial Overview
Table 6 Roche Diagnostics Company Overview
Table 7 Roche Diagnostics Financial Overview
Table 8 QIAGEN Company Overview
Table 9 QIAGEN Financial Overview
Table 10 Thermo Fisher Scientific Company Overview
Table 11 Thermo Fisher Scientific Financial Overview
Table 12 Illumina, Inc. Company Overview
Table 13 Illumina, Inc. Financial Overview
Table 14 PerkinElmer Company Overview
Table 15 PerkinElmer Financial Overview
Table 16 Hologic Company Overview
Table 17 Hologic Financial Overview
Table 18 Bio-Rad Laboratories Company Overview
Table 19 Bio-Rad Laboratories Financial Overview
Table 20 Agios Pharmaceuticals Company Overview
Table 21 Agios Pharmaceuticals Financial Overview
Table 22 Guardant Health Company Overview
Table 23 Guardant Health Financial Overview

LIST OF FIGURE

List of Figures
Figure 1 United States Solid Tumor Testing Segmentation
Figure 2 United States Solid Tumor Testing Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 United States Solid Tumor Testing Market Size, By Value (USD Million), 2019-2029
Figure 5 United States Solid Tumor Testing Market Share, By Testing Type, By Value, 2019-2029
Figure 6 United States Solid Tumor Testing Market Share, By Cancer Type, By Value, 2019-2029
Figure 7 United States Solid Tumor Testing Market Share, By End User, By Value, 2019-2029